Diabetes Detection Needs Better Tools. They’re on the Way

Blood glucose levels can be a reliable indicator of diabetes risk. But in some populations, it's not enough to catch the ...

Ascendis Pharma: New 2-Year Data from Pivotal ApproaCH Trial of TransCon CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged =5 Years

Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with achondroplasia =5 years of age at ...
The Manila Times

New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Age…

Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with ...